Phase II Study of Hyper-CVAD plus Nelarabine in Previously Untreated T-ALL and Lymphoblastic Lymphoma
The goal of this clinical research study is to learn the effectiveness of intensive chemotherapy given in combination with nelarabine (followed by maintenance therapy) in the treatment of patients with T cel ALL and T cell lymphoblastic lymphoma. The safety of this treatment will also be studied.
Treatment Location: N/A
1. To determine the complete remission (CR) rate and progression-free survival following treatment with hyper-CVAD in combination with nelarabine in previously untreated patients with T-cell ALL and T-cell lymphoblastic lymphoma. 2. To determine the safety and overall survival of previously untreated patients with T-cell ALL and T-cell lymphoblastic lymphoma.
IRB Review and Approval Date: 08/22/2006
Recruitment Status: Closed
Projected Accrual: N/A